Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2025-12-25 @ 4:55 AM
NCT ID:
NCT00653718
Eligibility Criteria:
Inclusion Criteria:
* Female
* Invasive carcinoma of the breast confirmed by needle biopsy or final pathological evaluation of the surgical specimen
* Breast cancer Stage I, II or IIIa
* ER and/or PR+
* No evidence of metastatic disease
* Post-menopausal
* May or may not have received adjuvant or neoadjuvant chemotherapy
* Bilateral infiltrating carcinoma are eligible
Exclusion Criteria:
* Men not eligible
* Other malignancies
* Patients who have received neoadjuvant or adjuvant endocrine therapy with tamoxifen or an aromatase inhibitor
* Ongoing treatment with any sex hormonal therapy (these patients are eligible if this therapy is discontinued prior to entry)
* Therapy with hormonal agent such as raloxifene for osteoporosis
* Patients receiving glucocorticoids
* Psychiatric or addictive disorders
* Inability to read English or French
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00653718
Study Brief:
Protocol Section:
NCT00653718